Lyrica（神経因性疼痛）：医薬品市場予測及び分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
3 Disease Overview 11
3.1 Clinical Manifestations of Neuropathic Pain – Signs and Symptoms 13
3.1.1 Painful Diabetic Neuropathy 15
3.1.2 Postherpetic Neuralgia 16
3.1.3 Trigeminal Neuralgia 16
3.2 Etiology and Pathophysiology 17
3.2.1 Etiology 18
3.2.2 Pathophysiology 19
4 Disease Management 27
4.1 Diagnosis and Treatment Overview 27
4.1.1 Diagnosis 27
4.1.2 Treatment Overview and Guidelines 34
5 Competitive Assessment 44
5.1 Overview 44
6 Lyrica 49
6.1 Overview 49
6.2 Efficacy 50
6.2.1 Painful Diabetic Neuropathy 50
6.2.2 Postherpetic Neuralgia 51
6.3 Safety 52
6.4 SWOT Analysis 52
6.5 Forecast 53
7 Appendix 55
7.1 Bibliography 55
7.2 Abbreviations 59
7.3 Methodology 62
7.4 Forecasting Methodology 62
7.4.1 Diagnosed PDN, PHN, and TN Patients 62
7.4.2 Percent Drug-Treated Patients 63
7.4.3 General Pricing Assumptions 63
7.4.4 Individual Drug Assumptions 64
7.4.5 Generic Erosion 64
7.5 Physicians and Specialists Included in This Study 65
7.6 About the Authors 67
7.6.1 Author 67
7.6.2 Global Head of Healthcare 68
7.7 About GlobalData 69
7.8 Disclaimer 69